When fiber reaches your colon, gut bacteria ferment it into short-chain fatty acids, which directly stimulate the L-cells to release GLP-1
Where Retatrutide Stands in Clinical Trials Retatrutide is currently in phase 3 evaluation through Eli Lilly's TRIUMPH trial programme, following phase 2 results showing up to 24.2% body weight loss over 48 weeks
Expert Guidance on GLP-1 Medications: We offer detailed education and support for patients using GLP-1 medications, including proper administration techniques and treatment adjustments
Concurrent medications can significantly impact results
For many patients, prescribing phentermine and topiramate separately provides the same therapeutic benefit at a fraction of the cost
Keep up with state legislation in the areas of pill presses, prescription drug affordability boards, drug importation, and med spas